advertisement
Goldberg I 155
Showing records 1 to 25 | Display only abstracts from Goldberg I in IGR 18-495875 Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry
Lawlor M; Nguyen V; Brooks A; Clement C; Craig JE; Danesh-Meyer H; Goldberg I; Graham SL; Grigg JR; Howes F; Lim R; Skalicky SE; White AJ; Gillies M
BMJ open ophthalmology 2021; 6: e000903 (IGR: 22-3)
91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Knight LSW; Ruddle JB; Taranath DA; Goldberg I; Smith JEH; Gole G; Chiang MY; Willett F; d'Mellow G; Breen J; Qassim A; Mullany S; Elder JE; Vincent AL; Staffieri SE; Kearns LS; Mackey DA; Luu S; Siggs OM; Souzeau E; Craig JE
Ophthalmology 2021; 0: (IGR: 22-1)
86292 Facilitating Patient-Ophthalmologist Dialog: A Call for a Patient-focused Classification of Glaucoma Diagnosis
Goldberg I; Ritch R; Goldmann N
Journal of Glaucoma 2020; 29: 329-330 (IGR: 21-2)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Topouzis F
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Ang GS; Fenwick EK
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Goldberg I
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Constantinou M
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Bell K; Tatham AJ
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Gan ATL; Man REK
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Ridolfi A
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Casson RJ
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Hubatsch D; Nicolela M
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Finkelstein EA; Goldberg I
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Denis P
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Healey PR
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Lerner SF
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)
82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Pesudovs K; Sanmugasundram S; Xie J; McIntosh R; Jackson J; Wells AP; White A; Martin K; Walland MJ; Crowston JG; Lamoureux EL
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)
80486 Current management of glaucoma
Lusthaus J; Goldberg I
The Medical journal of Australia 2019; 210: 180-187 (IGR: 20-3)
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Weinreb RN; Liebmann JM; Cioffi GA; Goldberg I; Brandt JD; Johnson CA; Zangwill LM; Schneider S; Badger H; Bejanian M
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)
78212 Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma
Macgregor S; Ong JS; An J; Han X; Zhou T; Siggs OM; Law MH; Souzeau E; Sharma S; Lynn DJ; Beesley J; Sheldrick B; Mills RA; Landers J; Ruddle JB; Graham SL; Healey PR; White AJR; Casson RJ; Best S; Grigg JR; Goldberg I; Powell JE; Whiteman DC; Radford-Smi
Nature Genetics 2018; 50: 1067-1071 (IGR: 19-4)
76513 Analysis combining correlated glaucoma traits identifies five new risk loci for open-angle glaucoma
Gharahkhani P
Scientific reports 2018; 8: 3124 (IGR: 19-3)
76501 The thick and thin of the central corneal thickness in glaucoma
Belovay GW
Eye 2018; 32: 915-923 (IGR: 19-3)
76513 Analysis combining correlated glaucoma traits identifies five new risk loci for open-angle glaucoma
Burdon KP
Scientific reports 2018; 8: 3124 (IGR: 19-3)
76501 The thick and thin of the central corneal thickness in glaucoma
Goldberg I
Eye 2018; 32: 915-923 (IGR: 19-3)
76513 Analysis combining correlated glaucoma traits identifies five new risk loci for open-angle glaucoma
Cooke Bailey JN; Hewitt AW; Law MH; Pasquale LR; Kang JH; Haines JL; Souzeau E; Zhou T; Siggs OM; Landers J; Awadalla M; Sharma S; Mills RA; Ridge B; Lynn D; Casson R; Graham SL; Goldberg I; White A; Healey PR; Grigg J; Lawlor M,
Scientific reports 2018; 8: 3124 (IGR: 19-3)
